Mike McSherry is the CEO of Xealth, the digital health orchestration company now operating inside Samsung Electronics. Xealth gives clinicians a way to prescribe and recommend far more than medication—including digital health apps, connected devices, remote-monitoring programs, transportation, meal delivery, and other services that increasingly shape a patient’s care journey.
The Samsung acquisition puts Xealth inside a company with a healthcare footprint far larger than most Americans realize. Samsung operates major hospitals, manufactures biologic medicines and medical equipment, develops healthcare robotics, and already has televisions, appliances, phones, watches, and other connected devices inside millions of American homes. Mike’s bet is that this existing footprint can become the infrastructure for aging in place, chronic-care management, fall detection, medication support, and earlier intervention—without making patients feel constantly watched or turning the home into a hospital.
That opportunity is becoming more immediate through the CMS ACCESS Model, a ten-year effort to bring technology-enabled, outcomes-based care to Medicare patients with chronic conditions. The model could allow companies offering services such as weight management, diabetes support, mental healthcare, wearable monitoring, and AI coaching to participate more directly in Medicare care delivery. Xealth can serve as the connective layer between health systems, clinicians, patients, and these new programs, while Samsung’s devices and consumer reach could support both monitoring and distribution.
Mike’s larger argument is that healthcare is approaching a data reset. Consumer technology companies and AI platforms are beginning to combine medical records, laboratory results, wearable signals, and patient-reported information into a more complete picture than many hospitals currently possess. Health systems and EHR companies that cannot absorb wearable data may lose relevance—but simply dumping more information on clinicians will make the problem worse. The real breakthrough will come from AI systems that filter continuous data, identify what actually matters, and surface only the moments that require human attention.
We discuss:
Why Samsung may have a better chance in home-based healthcare than Amazon, Walmart, Best Buy, and other major companies that struggled to turn consumer reach into sustained healthcare adoption
How Samsung’s hospitals, medical equipment, biologics manufacturing, robotics, wearables, smartphones, televisions, and connected appliances could become infrastructure for aging in place and chronic-care management
Why big technology companies repeatedly bounce off healthcare—and why the industry rewards trust, patience, integration, and long-term investment rather than quick wins and software-like margins
What the ten-year CMS ACCESS Model could change for Medicare patients with chronic conditions—and why companies such as Noom, WHOOP, Headspace, Lark, and Welldoc could begin operating more like technology-enabled care providers
How Xealth could connect clinicians and health systems with covered digital-health programs, while Samsung’s devices and consumer reach support patient monitoring, engagement, and distribution
Why EHRs that cannot absorb wearable data risk falling behind AI platforms and consumer-health companies that already combine medical records, laboratory results, and continuous biometric information
How AI could prevent physicians from drowning in streams of heart rate, temperature, oxygen, sleep, stress, and activity data by identifying the signals that actually require human intervention
Where wearables and connected care go next—from patches, earbuds, glasses, and implantables to household devices and robots that help patients remain independent without making their homes feel like hospitals
—
Brought to you by: Sage Growth Partners — Value-focused strategy and marketing for growth-driven healthcare organizations.
—
—
